company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,,2011-06-30,2011-08-08 16:23:12+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,81925000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,,2011-06-30,2011-08-08 16:23:12+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,17652000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,,2011-06-30,2011-08-08 16:23:12+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,363000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,,2011-06-30,2011-08-08 16:23:12+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1907000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,,2011-06-30,2011-08-08 16:23:12+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,101847000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,,2011-06-30,2011-08-08 16:23:12+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,825000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,,2011-06-30,2011-08-08 16:23:12+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,162000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,,2011-06-30,2011-08-08 16:23:12+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,162000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,,2011-06-30,2011-08-08 16:23:12+00:00,,totalassets,Total Assets,=,debit,usd,102834000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,,2011-06-30,2011-08-08 16:23:12+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,137000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,,2011-06-30,2011-08-08 16:23:12+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4168000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,,2011-06-30,2011-08-08 16:23:12+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,3735000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,,2011-06-30,2011-08-08 16:23:12+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,8040000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,,2011-06-30,2011-08-08 16:23:12+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,301000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,,2011-06-30,2011-08-08 16:23:12+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,2489000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,,2011-06-30,2011-08-08 16:23:12+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,2790000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,,2011-06-30,2011-08-08 16:23:12+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,10830000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,,2011-06-30,2011-08-08 16:23:12+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,,2011-06-30,2011-08-08 16:23:12+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,344777000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,,2011-06-30,2011-08-08 16:23:12+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-252777000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,,2011-06-30,2011-08-08 16:23:12+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,4000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,,2011-06-30,2011-08-08 16:23:12+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,92004000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,,2011-06-30,2011-08-08 16:23:12+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,92004000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,,2011-06-30,2011-08-08 16:23:12+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,92004000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,,2011-06-30,2011-08-08 16:23:12+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,102834000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,,2011-09-30,2011-11-08 16:07:41+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,23388000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,,2011-09-30,2011-11-08 16:07:41+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,41751000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,,2011-09-30,2011-11-08 16:07:41+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,93000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,,2011-09-30,2011-11-08 16:07:41+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2033000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,,2011-09-30,2011-11-08 16:07:41+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,67265000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,,2011-09-30,2011-11-08 16:07:41+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1060000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,,2011-09-30,2011-11-08 16:07:41+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,24861000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,,2011-09-30,2011-11-08 16:07:41+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,169000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,,2011-09-30,2011-11-08 16:07:41+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,25030000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,,2011-09-30,2011-11-08 16:07:41+00:00,,totalassets,Total Assets,=,debit,usd,93355000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,,2011-09-30,2011-11-08 16:07:41+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,139000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,,2011-09-30,2011-11-08 16:07:41+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4175000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,,2011-09-30,2011-11-08 16:07:41+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4092000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,,2011-09-30,2011-11-08 16:07:41+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,8406000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,,2011-09-30,2011-11-08 16:07:41+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,265000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,,2011-09-30,2011-11-08 16:07:41+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,2489000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,,2011-09-30,2011-11-08 16:07:41+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,2754000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,,2011-09-30,2011-11-08 16:07:41+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,11160000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,,2011-09-30,2011-11-08 16:07:41+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,,2011-09-30,2011-11-08 16:07:41+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,345453000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,,2011-09-30,2011-11-08 16:07:41+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-263215000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,,2011-09-30,2011-11-08 16:07:41+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-43000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,,2011-09-30,2011-11-08 16:07:41+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,82195000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,,2011-09-30,2011-11-08 16:07:41+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,82195000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,,2011-09-30,2011-11-08 16:07:41+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,82195000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,,2011-09-30,2011-11-08 16:07:41+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,93355000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,,2012-03-31,2012-05-09 16:12:14+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,29489000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,,2012-03-31,2012-05-09 16:12:14+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,35087000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,,2012-03-31,2012-05-09 16:12:14+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,17000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,,2012-03-31,2012-05-09 16:12:14+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2380000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,,2012-03-31,2012-05-09 16:12:14+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,66973000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,,2012-03-31,2012-05-09 16:12:14+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1371000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,,2012-03-31,2012-05-09 16:12:14+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,5453000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,,2012-03-31,2012-05-09 16:12:14+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,165000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,,2012-03-31,2012-05-09 16:12:14+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,5618000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,,2012-03-31,2012-05-09 16:12:14+00:00,,totalassets,Total Assets,=,debit,usd,73962000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,,2012-03-31,2012-05-09 16:12:14+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,333000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,,2012-03-31,2012-05-09 16:12:14+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4896000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,,2012-03-31,2012-05-09 16:12:14+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4169000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,,2012-03-31,2012-05-09 16:12:14+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,9398000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,,2012-03-31,2012-05-09 16:12:14+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,611000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,,2012-03-31,2012-05-09 16:12:14+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,611000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,,2012-03-31,2012-05-09 16:12:14+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,10009000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,,2012-03-31,2012-05-09 16:12:14+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,,2012-03-31,2012-05-09 16:12:14+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,348666000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,,2012-03-31,2012-05-09 16:12:14+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-284741000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,,2012-03-31,2012-05-09 16:12:14+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,28000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,,2012-03-31,2012-05-09 16:12:14+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,63953000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,,2012-03-31,2012-05-09 16:12:14+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,63953000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,,2012-03-31,2012-05-09 16:12:14+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,63953000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,,2012-03-31,2012-05-09 16:12:14+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,73962000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,,2012-06-30,2012-08-08 16:11:04+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,18264000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,,2012-06-30,2012-08-08 16:11:04+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,41692000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,,2012-06-30,2012-08-08 16:11:04+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,426000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,,2012-06-30,2012-08-08 16:11:04+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1935000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,,2012-06-30,2012-08-08 16:11:04+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,62317000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,,2012-06-30,2012-08-08 16:11:04+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1364000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,,2012-06-30,2012-08-08 16:11:04+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,164000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,,2012-06-30,2012-08-08 16:11:04+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,164000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,,2012-06-30,2012-08-08 16:11:04+00:00,,totalassets,Total Assets,=,debit,usd,63845000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,,2012-06-30,2012-08-08 16:11:04+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,339000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,,2012-06-30,2012-08-08 16:11:04+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4868000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,,2012-06-30,2012-08-08 16:11:04+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4722000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,,2012-06-30,2012-08-08 16:11:04+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,9929000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,,2012-06-30,2012-08-08 16:11:04+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,524000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,,2012-06-30,2012-08-08 16:11:04+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,524000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,,2012-06-30,2012-08-08 16:11:04+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,10453000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,,2012-06-30,2012-08-08 16:11:04+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,,2012-06-30,2012-08-08 16:11:04+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,349648000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,,2012-06-30,2012-08-08 16:11:04+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-296268000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,,2012-06-30,2012-08-08 16:11:04+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,12000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,,2012-06-30,2012-08-08 16:11:04+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,53392000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,,2012-06-30,2012-08-08 16:11:04+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,53392000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,,2012-06-30,2012-08-08 16:11:04+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,53392000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,,2012-06-30,2012-08-08 16:11:04+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,63845000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,,2012-09-30,2012-11-08 16:34:13+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,20841000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,,2012-09-30,2012-11-08 16:34:13+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,60066000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,,2012-09-30,2012-11-08 16:34:13+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,463000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,,2012-09-30,2012-11-08 16:34:13+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2290000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,,2012-09-30,2012-11-08 16:34:13+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,83660000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,,2012-09-30,2012-11-08 16:34:13+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1308000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,,2012-09-30,2012-11-08 16:34:13+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,9741000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,,2012-09-30,2012-11-08 16:34:13+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,162000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,,2012-09-30,2012-11-08 16:34:13+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,9903000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,,2012-09-30,2012-11-08 16:34:13+00:00,,totalassets,Total Assets,=,debit,usd,94871000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,,2012-09-30,2012-11-08 16:34:13+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,345000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,,2012-09-30,2012-11-08 16:34:13+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5866000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,,2012-09-30,2012-11-08 16:34:13+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6549000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,,2012-09-30,2012-11-08 16:34:13+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,12760000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,,2012-09-30,2012-11-08 16:34:13+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,436000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,,2012-09-30,2012-11-08 16:34:13+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,,2012-09-30,2012-11-08 16:34:13+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,436000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,,2012-09-30,2012-11-08 16:34:13+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,13196000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,,2012-09-30,2012-11-08 16:34:13+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,,2012-09-30,2012-11-08 16:34:13+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,393153000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,,2012-09-30,2012-11-08 16:34:13+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-311523000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,,2012-09-30,2012-11-08 16:34:13+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,45000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,,2012-09-30,2012-11-08 16:34:13+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,81675000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,,2012-09-30,2012-11-08 16:34:13+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,81675000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,,2012-09-30,2012-11-08 16:34:13+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,81675000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,,2012-09-30,2012-11-08 16:34:13+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,94871000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,,2013-03-31,2013-05-07 16:08:53+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,39398000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,,2013-03-31,2013-05-07 16:08:53+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,105595000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,,2013-03-31,2013-05-07 16:08:53+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,589000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,,2013-03-31,2013-05-07 16:08:53+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3775000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,,2013-03-31,2013-05-07 16:08:53+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,149357000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,,2013-03-31,2013-05-07 16:08:53+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1301000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,,2013-03-31,2013-05-07 16:08:53+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,54946000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,,2013-03-31,2013-05-07 16:08:53+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,231000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,,2013-03-31,2013-05-07 16:08:53+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,55177000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,,2013-03-31,2013-05-07 16:08:53+00:00,,totalassets,Total Assets,=,debit,usd,205835000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,,2013-03-31,2013-05-07 16:08:53+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,356000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,,2013-03-31,2013-05-07 16:08:53+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5193000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,,2013-03-31,2013-05-07 16:08:53+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5031000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,,2013-03-31,2013-05-07 16:08:53+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,10580000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,,2013-03-31,2013-05-07 16:08:53+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,255000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,,2013-03-31,2013-05-07 16:08:53+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,255000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,,2013-03-31,2013-05-07 16:08:53+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,10835000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,,2013-03-31,2013-05-07 16:08:53+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,,2013-03-31,2013-05-07 16:08:53+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,529496000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,,2013-03-31,2013-05-07 16:08:53+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-334465000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,,2013-03-31,2013-05-07 16:08:53+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-31000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,,2013-03-31,2013-05-07 16:08:53+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,195000000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,,2013-03-31,2013-05-07 16:08:53+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,195000000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,,2013-03-31,2013-05-07 16:08:53+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,195000000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,,2013-03-31,2013-05-07 16:08:53+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,205835000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q2,,2013-06-30,2013-08-07 16:30:54+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,17237000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q2,,2013-06-30,2013-08-07 16:30:54+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,116583000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q2,,2013-06-30,2013-08-07 16:30:54+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,609000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q2,,2013-06-30,2013-08-07 16:30:54+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2619000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q2,,2013-06-30,2013-08-07 16:30:54+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,137048000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q2,,2013-06-30,2013-08-07 16:30:54+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1297000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q2,,2013-06-30,2013-08-07 16:30:54+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,52352000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q2,,2013-06-30,2013-08-07 16:30:54+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,231000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q2,,2013-06-30,2013-08-07 16:30:54+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,52583000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q2,,2013-06-30,2013-08-07 16:30:54+00:00,,totalassets,Total Assets,=,debit,usd,190928000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q2,,2013-06-30,2013-08-07 16:30:54+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,361000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q2,,2013-06-30,2013-08-07 16:30:54+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6561000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q2,,2013-06-30,2013-08-07 16:30:54+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6932000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q2,,2013-06-30,2013-08-07 16:30:54+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,13854000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q2,,2013-06-30,2013-08-07 16:30:54+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,164000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q2,,2013-06-30,2013-08-07 16:30:54+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,164000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q2,,2013-06-30,2013-08-07 16:30:54+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,14018000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q2,,2013-06-30,2013-08-07 16:30:54+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q2,,2013-06-30,2013-08-07 16:30:54+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,531456000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q2,,2013-06-30,2013-08-07 16:30:54+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-354405000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q2,,2013-06-30,2013-08-07 16:30:54+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-141000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q2,,2013-06-30,2013-08-07 16:30:54+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,176910000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q2,,2013-06-30,2013-08-07 16:30:54+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,176910000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q2,,2013-06-30,2013-08-07 16:30:54+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,176910000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q2,,2013-06-30,2013-08-07 16:30:54+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,190928000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q3,,2013-09-30,2013-11-12 16:29:49+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,25630000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q3,,2013-09-30,2013-11-12 16:29:49+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,114138000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q3,,2013-09-30,2013-11-12 16:29:49+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,36000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q3,,2013-09-30,2013-11-12 16:29:49+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2129000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q3,,2013-09-30,2013-11-12 16:29:49+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,141933000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q3,,2013-09-30,2013-11-12 16:29:49+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1205000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q3,,2013-09-30,2013-11-12 16:29:49+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,32692000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q3,,2013-09-30,2013-11-12 16:29:49+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,231000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q3,,2013-09-30,2013-11-12 16:29:49+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,32923000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q3,,2013-09-30,2013-11-12 16:29:49+00:00,,totalassets,Total Assets,=,debit,usd,176061000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q3,,2013-09-30,2013-11-12 16:29:49+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,326000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q3,,2013-09-30,2013-11-12 16:29:49+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4845000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q3,,2013-09-30,2013-11-12 16:29:49+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6367000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q3,,2013-09-30,2013-11-12 16:29:49+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,11538000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q3,,2013-09-30,2013-11-12 16:29:49+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,110000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q3,,2013-09-30,2013-11-12 16:29:49+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,110000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q3,,2013-09-30,2013-11-12 16:29:49+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,11648000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q3,,2013-09-30,2013-11-12 16:29:49+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q3,,2013-09-30,2013-11-12 16:29:49+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,532728000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q3,,2013-09-30,2013-11-12 16:29:49+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-368324000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q3,,2013-09-30,2013-11-12 16:29:49+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,9000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q3,,2013-09-30,2013-11-12 16:29:49+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,164413000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q3,,2013-09-30,2013-11-12 16:29:49+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,164413000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q3,,2013-09-30,2013-11-12 16:29:49+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,164413000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q3,,2013-09-30,2013-11-12 16:29:49+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,176061000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,,2014-03-31,2014-05-07 15:58:50+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,34121000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,,2014-03-31,2014-05-07 15:58:50+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,106417000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,,2014-03-31,2014-05-07 15:58:50+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,633000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,,2014-03-31,2014-05-07 15:58:50+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1460000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,,2014-03-31,2014-05-07 15:58:50+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,142631000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,,2014-03-31,2014-05-07 15:58:50+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1372000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,,2014-03-31,2014-05-07 15:58:50+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,3671000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,,2014-03-31,2014-05-07 15:58:50+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,308000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,,2014-03-31,2014-05-07 15:58:50+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3979000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,,2014-03-31,2014-05-07 15:58:50+00:00,,totalassets,Total Assets,=,debit,usd,147982000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,,2014-03-31,2014-05-07 15:58:50+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,256000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,,2014-03-31,2014-05-07 15:58:50+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3641000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,,2014-03-31,2014-05-07 15:58:50+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5636000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,,2014-03-31,2014-05-07 15:58:50+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,9533000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,,2014-03-31,2014-05-07 15:58:50+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,,2014-03-31,2014-05-07 15:58:50+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,9533000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,,2014-03-31,2014-05-07 15:58:50+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,,2014-03-31,2014-05-07 15:58:50+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,536187000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,,2014-03-31,2014-05-07 15:58:50+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-397762000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,,2014-03-31,2014-05-07 15:58:50+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,24000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,,2014-03-31,2014-05-07 15:58:50+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,138449000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,,2014-03-31,2014-05-07 15:58:50+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,138449000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,,2014-03-31,2014-05-07 15:58:50+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,138449000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,,2014-03-31,2014-05-07 15:58:50+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,147982000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,,2014-06-30,2014-08-07 16:01:58+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,33268000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,,2014-06-30,2014-08-07 16:01:58+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,98205000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,,2014-06-30,2014-08-07 16:01:58+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,194000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,,2014-06-30,2014-08-07 16:01:58+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1923000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,,2014-06-30,2014-08-07 16:01:58+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,133590000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,,2014-06-30,2014-08-07 16:01:58+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1279000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,,2014-06-30,2014-08-07 16:01:58+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,,2014-06-30,2014-08-07 16:01:58+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,313000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,,2014-06-30,2014-08-07 16:01:58+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,313000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,,2014-06-30,2014-08-07 16:01:58+00:00,,totalassets,Total Assets,=,debit,usd,135182000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,,2014-06-30,2014-08-07 16:01:58+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,164000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,,2014-06-30,2014-08-07 16:01:58+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2004000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,,2014-06-30,2014-08-07 16:01:58+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,7039000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,,2014-06-30,2014-08-07 16:01:58+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,9207000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,,2014-06-30,2014-08-07 16:01:58+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,,2014-06-30,2014-08-07 16:01:58+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,9207000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,,2014-06-30,2014-08-07 16:01:58+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,,2014-06-30,2014-08-07 16:01:58+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,539369000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,,2014-06-30,2014-08-07 16:01:58+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-413419000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,,2014-06-30,2014-08-07 16:01:58+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,25000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,,2014-06-30,2014-08-07 16:01:58+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,125975000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,,2014-06-30,2014-08-07 16:01:58+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,125975000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,,2014-06-30,2014-08-07 16:01:58+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,125975000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,,2014-06-30,2014-08-07 16:01:58+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,135182000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q3,,2014-09-30,2014-11-04 16:08:54+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,39610000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q3,,2014-09-30,2014-11-04 16:08:54+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,87009000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q3,,2014-09-30,2014-11-04 16:08:54+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,42000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q3,,2014-09-30,2014-11-04 16:08:54+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2016000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q3,,2014-09-30,2014-11-04 16:08:54+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,128677000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q3,,2014-09-30,2014-11-04 16:08:54+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1581000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q3,,2014-09-30,2014-11-04 16:08:54+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q3,,2014-09-30,2014-11-04 16:08:54+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,313000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q3,,2014-09-30,2014-11-04 16:08:54+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,313000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q3,,2014-09-30,2014-11-04 16:08:54+00:00,,totalassets,Total Assets,=,debit,usd,130571000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q3,,2014-09-30,2014-11-04 16:08:54+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,110000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q3,,2014-09-30,2014-11-04 16:08:54+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2636000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q3,,2014-09-30,2014-11-04 16:08:54+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,8222000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q3,,2014-09-30,2014-11-04 16:08:54+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,10968000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q3,,2014-09-30,2014-11-04 16:08:54+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q3,,2014-09-30,2014-11-04 16:08:54+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,10968000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q3,,2014-09-30,2014-11-04 16:08:54+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q3,,2014-09-30,2014-11-04 16:08:54+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,548696000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q3,,2014-09-30,2014-11-04 16:08:54+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-429086000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q3,,2014-09-30,2014-11-04 16:08:54+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-7000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q3,,2014-09-30,2014-11-04 16:08:54+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,119603000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q3,,2014-09-30,2014-11-04 16:08:54+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,119603000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q3,,2014-09-30,2014-11-04 16:08:54+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,119603000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q3,,2014-09-30,2014-11-04 16:08:54+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,130571000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,,2015-03-31,2015-05-07 07:34:52+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,46723000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,,2015-03-31,2015-05-07 07:34:52+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,206518000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,,2015-03-31,2015-05-07 07:34:52+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,806000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,,2015-03-31,2015-05-07 07:34:52+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1531000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,,2015-03-31,2015-05-07 07:34:52+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,255578000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,,2015-03-31,2015-05-07 07:34:52+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1718000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,,2015-03-31,2015-05-07 07:34:52+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,21914000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,,2015-03-31,2015-05-07 07:34:52+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,53000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,,2015-03-31,2015-05-07 07:34:52+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,152000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,,2015-03-31,2015-05-07 07:34:52+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,22119000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,,2015-03-31,2015-05-07 07:34:52+00:00,,totalassets,Total Assets,=,debit,usd,279415000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,,2015-03-31,2015-05-07 07:34:52+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,213000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,,2015-03-31,2015-05-07 07:34:52+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,8015000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,,2015-03-31,2015-05-07 07:34:52+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4786000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,,2015-03-31,2015-05-07 07:34:52+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,13014000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,,2015-03-31,2015-05-07 07:34:52+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,400000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,,2015-03-31,2015-05-07 07:34:52+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,400000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,,2015-03-31,2015-05-07 07:34:52+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,13414000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,,2015-03-31,2015-05-07 07:34:52+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,,2015-03-31,2015-05-07 07:34:52+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,735898000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,,2015-03-31,2015-05-07 07:34:52+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-469945000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,,2015-03-31,2015-05-07 07:34:52+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,48000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,,2015-03-31,2015-05-07 07:34:52+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,266001000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,,2015-03-31,2015-05-07 07:34:52+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,266001000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,,2015-03-31,2015-05-07 07:34:52+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,266001000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,,2015-03-31,2015-05-07 07:34:52+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,279415000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,,2015-06-30,2015-08-10 16:09:15+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,61698000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,,2015-06-30,2015-08-10 16:09:15+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,184051000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,,2015-06-30,2015-08-10 16:09:15+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1452000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,,2015-06-30,2015-08-10 16:09:15+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2315000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,,2015-06-30,2015-08-10 16:09:15+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,249516000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,,2015-06-30,2015-08-10 16:09:15+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1871000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,,2015-06-30,2015-08-10 16:09:15+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,14511000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,,2015-06-30,2015-08-10 16:09:15+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,41000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,,2015-06-30,2015-08-10 16:09:15+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,152000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,,2015-06-30,2015-08-10 16:09:15+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,14704000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,,2015-06-30,2015-08-10 16:09:15+00:00,,totalassets,Total Assets,=,debit,usd,266091000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,,2015-06-30,2015-08-10 16:09:15+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,216000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,,2015-06-30,2015-08-10 16:09:15+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,11547000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,,2015-06-30,2015-08-10 16:09:15+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,12053000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,,2015-06-30,2015-08-10 16:09:15+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,23816000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,,2015-06-30,2015-08-10 16:09:15+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,345000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,,2015-06-30,2015-08-10 16:09:15+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,345000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,,2015-06-30,2015-08-10 16:09:15+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,24161000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,,2015-06-30,2015-08-10 16:09:15+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,,2015-06-30,2015-08-10 16:09:15+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,740885000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,,2015-06-30,2015-08-10 16:09:15+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-498923000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,,2015-06-30,2015-08-10 16:09:15+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-32000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,,2015-06-30,2015-08-10 16:09:15+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,241930000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,,2015-06-30,2015-08-10 16:09:15+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,241930000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,,2015-06-30,2015-08-10 16:09:15+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,241930000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,,2015-06-30,2015-08-10 16:09:15+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,266091000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,,2015-09-30,2015-11-05 16:18:41+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,150431000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,,2015-09-30,2015-11-05 16:18:41+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,312277000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,,2015-09-30,2015-11-05 16:18:41+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,378000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,,2015-09-30,2015-11-05 16:18:41+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2172000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,,2015-09-30,2015-11-05 16:18:41+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,465258000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,,2015-09-30,2015-11-05 16:18:41+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1880000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,,2015-09-30,2015-11-05 16:18:41+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,12182000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,,2015-09-30,2015-11-05 16:18:41+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,39000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,,2015-09-30,2015-11-05 16:18:41+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,152000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,,2015-09-30,2015-11-05 16:18:41+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,12373000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,,2015-09-30,2015-11-05 16:18:41+00:00,,totalassets,Total Assets,=,debit,usd,479511000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,,2015-09-30,2015-11-05 16:18:41+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,219000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,,2015-09-30,2015-11-05 16:18:41+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4946000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,,2015-09-30,2015-11-05 16:18:41+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,12726000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,,2015-09-30,2015-11-05 16:18:41+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,31592000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,,2015-09-30,2015-11-05 16:18:41+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,49483000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,,2015-09-30,2015-11-05 16:18:41+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,288000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,,2015-09-30,2015-11-05 16:18:41+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,288000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,,2015-09-30,2015-11-05 16:18:41+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,49771000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,,2015-09-30,2015-11-05 16:18:41+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,,2015-09-30,2015-11-05 16:18:41+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,902394000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,,2015-09-30,2015-11-05 16:18:41+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-472664000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,,2015-09-30,2015-11-05 16:18:41+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,10000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,,2015-09-30,2015-11-05 16:18:41+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,429740000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,,2015-09-30,2015-11-05 16:18:41+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,429740000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,,2015-09-30,2015-11-05 16:18:41+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,429740000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,,2015-09-30,2015-11-05 16:18:41+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,479511000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,,2016-03-31,2016-05-03 16:12:56+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,58745000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,,2016-03-31,2016-05-03 16:12:56+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,381102000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,,2016-03-31,2016-05-03 16:12:56+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,917000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,,2016-03-31,2016-05-03 16:12:56+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2277000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,,2016-03-31,2016-05-03 16:12:56+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,443041000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,,2016-03-31,2016-05-03 16:12:56+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2377000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,,2016-03-31,2016-05-03 16:12:56+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,3034000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,,2016-03-31,2016-05-03 16:12:56+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,52000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,,2016-03-31,2016-05-03 16:12:56+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,152000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,,2016-03-31,2016-05-03 16:12:56+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3238000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,,2016-03-31,2016-05-03 16:12:56+00:00,,totalassets,Total Assets,=,debit,usd,448656000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,,2016-03-31,2016-05-03 16:12:56+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,227000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,,2016-03-31,2016-05-03 16:12:56+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6583000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,,2016-03-31,2016-05-03 16:12:56+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6653000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,,2016-03-31,2016-05-03 16:12:56+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,13463000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,,2016-03-31,2016-05-03 16:12:56+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,173000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,,2016-03-31,2016-05-03 16:12:56+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,152000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,,2016-03-31,2016-05-03 16:12:56+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,325000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,,2016-03-31,2016-05-03 16:12:56+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,13788000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,,2016-03-31,2016-05-03 16:12:56+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,,2016-03-31,2016-05-03 16:12:56+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,908369000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,,2016-03-31,2016-05-03 16:12:56+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-473766000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,,2016-03-31,2016-05-03 16:12:56+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,265000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,,2016-03-31,2016-05-03 16:12:56+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,434868000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,,2016-03-31,2016-05-03 16:12:56+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,434868000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,,2016-03-31,2016-05-03 16:12:56+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,434868000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,,2016-03-31,2016-05-03 16:12:56+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,448656000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,,2016-06-30,2016-08-04 16:13:50+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,33777000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,,2016-06-30,2016-08-04 16:13:50+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,391429000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,,2016-06-30,2016-08-04 16:13:50+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,886000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,,2016-06-30,2016-08-04 16:13:50+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3008000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,,2016-06-30,2016-08-04 16:13:50+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,429100000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,,2016-06-30,2016-08-04 16:13:50+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3019000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,,2016-06-30,2016-08-04 16:13:50+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,84000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,,2016-06-30,2016-08-04 16:13:50+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,152000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,,2016-06-30,2016-08-04 16:13:50+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,236000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,,2016-06-30,2016-08-04 16:13:50+00:00,,totalassets,Total Assets,=,debit,usd,432355000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,,2016-06-30,2016-08-04 16:13:50+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,230000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,,2016-06-30,2016-08-04 16:13:50+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5811000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,,2016-06-30,2016-08-04 16:13:50+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6795000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,,2016-06-30,2016-08-04 16:13:50+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,12836000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,,2016-06-30,2016-08-04 16:13:50+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,114000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,,2016-06-30,2016-08-04 16:13:50+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,150000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,,2016-06-30,2016-08-04 16:13:50+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,264000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,,2016-06-30,2016-08-04 16:13:50+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,13100000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,,2016-06-30,2016-08-04 16:13:50+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,,2016-06-30,2016-08-04 16:13:50+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,911203000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,,2016-06-30,2016-08-04 16:13:50+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-492259000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,,2016-06-30,2016-08-04 16:13:50+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,311000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,,2016-06-30,2016-08-04 16:13:50+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,419255000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,,2016-06-30,2016-08-04 16:13:50+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,419255000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,,2016-06-30,2016-08-04 16:13:50+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,419255000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,,2016-06-30,2016-08-04 16:13:50+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,432355000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q3,,2016-09-30,2016-11-03 16:18:57+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,40362000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q3,,2016-09-30,2016-11-03 16:18:57+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,368343000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q3,,2016-09-30,2016-11-03 16:18:57+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,385000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q3,,2016-09-30,2016-11-03 16:18:57+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2753000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q3,,2016-09-30,2016-11-03 16:18:57+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,411843000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q3,,2016-09-30,2016-11-03 16:18:57+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3145000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q3,,2016-09-30,2016-11-03 16:18:57+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,53000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q3,,2016-09-30,2016-11-03 16:18:57+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,152000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q3,,2016-09-30,2016-11-03 16:18:57+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,205000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q3,,2016-09-30,2016-11-03 16:18:57+00:00,,totalassets,Total Assets,=,debit,usd,415193000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q3,,2016-09-30,2016-11-03 16:18:57+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,234000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q3,,2016-09-30,2016-11-03 16:18:57+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5449000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q3,,2016-09-30,2016-11-03 16:18:57+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,8078000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q3,,2016-09-30,2016-11-03 16:18:57+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,13761000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q3,,2016-09-30,2016-11-03 16:18:57+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,55000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q3,,2016-09-30,2016-11-03 16:18:57+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,166000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q3,,2016-09-30,2016-11-03 16:18:57+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,221000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q3,,2016-09-30,2016-11-03 16:18:57+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,13982000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q3,,2016-09-30,2016-11-03 16:18:57+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q3,,2016-09-30,2016-11-03 16:18:57+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,913890000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q3,,2016-09-30,2016-11-03 16:18:57+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-512989000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q3,,2016-09-30,2016-11-03 16:18:57+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,310000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q3,,2016-09-30,2016-11-03 16:18:57+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,401211000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q3,,2016-09-30,2016-11-03 16:18:57+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,401211000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q3,,2016-09-30,2016-11-03 16:18:57+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,401211000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q3,,2016-09-30,2016-11-03 16:18:57+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,415193000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,,2017-03-31,2017-05-04 16:45:50+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,43079000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,,2017-03-31,2017-05-04 16:45:50+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,336022000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,,2017-03-31,2017-05-04 16:45:50+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,459000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,,2017-03-31,2017-05-04 16:45:50+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3866000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,,2017-03-31,2017-05-04 16:45:50+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,383426000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,,2017-03-31,2017-05-04 16:45:50+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3281000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,,2017-03-31,2017-05-04 16:45:50+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,6273000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,,2017-03-31,2017-05-04 16:45:50+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,221000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,,2017-03-31,2017-05-04 16:45:50+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,152000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,,2017-03-31,2017-05-04 16:45:50+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,6646000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,,2017-03-31,2017-05-04 16:45:50+00:00,,totalassets,Total Assets,=,debit,usd,393353000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,,2017-03-31,2017-05-04 16:45:50+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,316000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,,2017-03-31,2017-05-04 16:45:50+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4128000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,,2017-03-31,2017-05-04 16:45:50+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6187000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,,2017-03-31,2017-05-04 16:45:50+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,10631000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,,2017-03-31,2017-05-04 16:45:50+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,243000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,,2017-03-31,2017-05-04 16:45:50+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,133000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,,2017-03-31,2017-05-04 16:45:50+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,376000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,,2017-03-31,2017-05-04 16:45:50+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,11007000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,,2017-03-31,2017-05-04 16:45:50+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,,2017-03-31,2017-05-04 16:45:50+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,919899000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,,2017-03-31,2017-05-04 16:45:50+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-537570000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,,2017-03-31,2017-05-04 16:45:50+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,17000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,,2017-03-31,2017-05-04 16:45:50+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,382346000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,,2017-03-31,2017-05-04 16:45:50+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,382346000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,,2017-03-31,2017-05-04 16:45:50+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,382346000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,,2017-03-31,2017-05-04 16:45:50+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,393353000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,,2017-06-30,2017-08-08 16:03:51+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,35391000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,,2017-06-30,2017-08-08 16:03:51+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,315064000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,,2017-06-30,2017-08-08 16:03:51+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,229000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,,2017-06-30,2017-08-08 16:03:51+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4472000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,,2017-06-30,2017-08-08 16:03:51+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,355156000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,,2017-06-30,2017-08-08 16:03:51+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3135000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,,2017-06-30,2017-08-08 16:03:51+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,18268000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,,2017-06-30,2017-08-08 16:03:51+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,208000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,,2017-06-30,2017-08-08 16:03:51+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,152000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,,2017-06-30,2017-08-08 16:03:51+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,18628000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,,2017-06-30,2017-08-08 16:03:51+00:00,,totalassets,Total Assets,=,debit,usd,376919000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,,2017-06-30,2017-08-08 16:03:51+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,259000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,,2017-06-30,2017-08-08 16:03:51+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2956000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,,2017-06-30,2017-08-08 16:03:51+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,10805000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,,2017-06-30,2017-08-08 16:03:51+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,14020000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,,2017-06-30,2017-08-08 16:03:51+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,207000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,,2017-06-30,2017-08-08 16:03:51+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,116000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,,2017-06-30,2017-08-08 16:03:51+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,323000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,,2017-06-30,2017-08-08 16:03:51+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,14343000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,,2017-06-30,2017-08-08 16:03:51+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,,2017-06-30,2017-08-08 16:03:51+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,922809000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,,2017-06-30,2017-08-08 16:03:51+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-560113000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,,2017-06-30,2017-08-08 16:03:51+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-120000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,,2017-06-30,2017-08-08 16:03:51+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,362576000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,,2017-06-30,2017-08-08 16:03:51+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,362576000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,,2017-06-30,2017-08-08 16:03:51+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,362576000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,,2017-06-30,2017-08-08 16:03:51+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,376919000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,,2017-09-30,2017-11-01 16:11:55+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,52094000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,,2017-09-30,2017-11-01 16:11:55+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,269636000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,,2017-09-30,2017-11-01 16:11:55+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,291000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,,2017-09-30,2017-11-01 16:11:55+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4985000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,,2017-09-30,2017-11-01 16:11:55+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,327006000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,,2017-09-30,2017-11-01 16:11:55+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3013000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,,2017-09-30,2017-11-01 16:11:55+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,30065000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,,2017-09-30,2017-11-01 16:11:55+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,206000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,,2017-09-30,2017-11-01 16:11:55+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,152000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,,2017-09-30,2017-11-01 16:11:55+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,30423000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,,2017-09-30,2017-11-01 16:11:55+00:00,,totalassets,Total Assets,=,debit,usd,360442000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,,2017-09-30,2017-11-01 16:11:55+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,201000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,,2017-09-30,2017-11-01 16:11:55+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,8133000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,,2017-09-30,2017-11-01 16:11:55+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6102000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,,2017-09-30,2017-11-01 16:11:55+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,14436000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,,2017-09-30,2017-11-01 16:11:55+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,169000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,,2017-09-30,2017-11-01 16:11:55+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,100000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,,2017-09-30,2017-11-01 16:11:55+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,269000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,,2017-09-30,2017-11-01 16:11:55+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,14705000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,,2017-09-30,2017-11-01 16:11:55+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,,2017-09-30,2017-11-01 16:11:55+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,925251000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,,2017-09-30,2017-11-01 16:11:55+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-579451000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,,2017-09-30,2017-11-01 16:11:55+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-63000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,,2017-09-30,2017-11-01 16:11:55+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,345737000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,,2017-09-30,2017-11-01 16:11:55+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,345737000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,,2017-09-30,2017-11-01 16:11:55+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,345737000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,,2017-09-30,2017-11-01 16:11:55+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,360442000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,,2018-03-31,2018-05-02 06:41:46+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,36922000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,,2018-03-31,2018-05-02 06:41:46+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,266942000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,,2018-03-31,2018-05-02 06:41:46+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,350000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,,2018-03-31,2018-05-02 06:41:46+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,5286000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,,2018-03-31,2018-05-02 06:41:46+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,309500000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,,2018-03-31,2018-05-02 06:41:46+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2737000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,,2018-03-31,2018-05-02 06:41:46+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,2989000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,,2018-03-31,2018-05-02 06:41:46+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,188000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,,2018-03-31,2018-05-02 06:41:46+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,152000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,,2018-03-31,2018-05-02 06:41:46+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3329000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,,2018-03-31,2018-05-02 06:41:46+00:00,,totalassets,Total Assets,=,debit,usd,315566000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,,2018-03-31,2018-05-02 06:41:46+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,151000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,,2018-03-31,2018-05-02 06:41:46+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2445000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,,2018-03-31,2018-05-02 06:41:46+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5542000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,,2018-03-31,2018-05-02 06:41:46+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,8138000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,,2018-03-31,2018-05-02 06:41:46+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,92000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,,2018-03-31,2018-05-02 06:41:46+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,66000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,,2018-03-31,2018-05-02 06:41:46+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,158000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,,2018-03-31,2018-05-02 06:41:46+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,8296000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,,2018-03-31,2018-05-02 06:41:46+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,,2018-03-31,2018-05-02 06:41:46+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,931197000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,,2018-03-31,2018-05-02 06:41:46+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-623242000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,,2018-03-31,2018-05-02 06:41:46+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-685000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,,2018-03-31,2018-05-02 06:41:46+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,307270000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,,2018-03-31,2018-05-02 06:41:46+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,307270000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,,2018-03-31,2018-05-02 06:41:46+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,307270000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,,2018-03-31,2018-05-02 06:41:46+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,315566000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,,2018-06-30,2018-08-08 16:11:56+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,35121000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,,2018-06-30,2018-08-08 16:11:56+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,251624000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,,2018-06-30,2018-08-08 16:11:56+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,318000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,,2018-06-30,2018-08-08 16:11:56+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4842000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,,2018-06-30,2018-08-08 16:11:56+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,291905000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,,2018-06-30,2018-08-08 16:11:56+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2606000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,,2018-06-30,2018-08-08 16:11:56+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,7928000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,,2018-06-30,2018-08-08 16:11:56+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,198000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,,2018-06-30,2018-08-08 16:11:56+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,152000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,,2018-06-30,2018-08-08 16:11:56+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,8278000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,,2018-06-30,2018-08-08 16:11:56+00:00,,totalassets,Total Assets,=,debit,usd,302789000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,,2018-06-30,2018-08-08 16:11:56+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,153000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,,2018-06-30,2018-08-08 16:11:56+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1390000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,,2018-06-30,2018-08-08 16:11:56+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6584000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,,2018-06-30,2018-08-08 16:11:56+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,8127000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,,2018-06-30,2018-08-08 16:11:56+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,53000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,,2018-06-30,2018-08-08 16:11:56+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,50000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,,2018-06-30,2018-08-08 16:11:56+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,103000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,,2018-06-30,2018-08-08 16:11:56+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,8230000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,,2018-06-30,2018-08-08 16:11:56+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,,2018-06-30,2018-08-08 16:11:56+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,935419000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,,2018-06-30,2018-08-08 16:11:56+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-640441000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,,2018-06-30,2018-08-08 16:11:56+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-419000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,,2018-06-30,2018-08-08 16:11:56+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,294559000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,,2018-06-30,2018-08-08 16:11:56+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,294559000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,,2018-06-30,2018-08-08 16:11:56+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,294559000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,,2018-06-30,2018-08-08 16:11:56+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,302789000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,,2018-09-30,2018-11-07 16:03:54+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,36291000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,,2018-09-30,2018-11-07 16:03:54+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,245775000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,,2018-09-30,2018-11-07 16:03:54+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,82000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,,2018-09-30,2018-11-07 16:03:54+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4286000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,,2018-09-30,2018-11-07 16:03:54+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,286434000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,,2018-09-30,2018-11-07 16:03:54+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2400000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,,2018-09-30,2018-11-07 16:03:54+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,,2018-09-30,2018-11-07 16:03:54+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,191000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,,2018-09-30,2018-11-07 16:03:54+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,152000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,,2018-09-30,2018-11-07 16:03:54+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,343000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,,2018-09-30,2018-11-07 16:03:54+00:00,,totalassets,Total Assets,=,debit,usd,289177000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,,2018-09-30,2018-11-07 16:03:54+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,156000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,,2018-09-30,2018-11-07 16:03:54+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1597000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,,2018-09-30,2018-11-07 16:03:54+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6871000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,,2018-09-30,2018-11-07 16:03:54+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,8624000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,,2018-09-30,2018-11-07 16:03:54+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,13000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,,2018-09-30,2018-11-07 16:03:54+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,34000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,,2018-09-30,2018-11-07 16:03:54+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,47000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,,2018-09-30,2018-11-07 16:03:54+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,8671000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,,2018-09-30,2018-11-07 16:03:54+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,,2018-09-30,2018-11-07 16:03:54+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,937039000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,,2018-09-30,2018-11-07 16:03:54+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-656325000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,,2018-09-30,2018-11-07 16:03:54+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-208000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,,2018-09-30,2018-11-07 16:03:54+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,280506000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,,2018-09-30,2018-11-07 16:03:54+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,280506000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,,2018-09-30,2018-11-07 16:03:54+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,280506000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,,2018-09-30,2018-11-07 16:03:54+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,289177000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,,2019-03-31,2019-05-09 16:03:06+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,49491000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,,2019-03-31,2019-05-09 16:03:06+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,204577000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,,2019-03-31,2019-05-09 16:03:06+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1216000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,,2019-03-31,2019-05-09 16:03:06+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3806000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,,2019-03-31,2019-05-09 16:03:06+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,259090000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,,2019-03-31,2019-05-09 16:03:06+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1858000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,,2019-03-31,2019-05-09 16:03:06+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1577000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,,2019-03-31,2019-05-09 16:03:06+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,152000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,,2019-03-31,2019-05-09 16:03:06+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1729000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,,2019-03-31,2019-05-09 16:03:06+00:00,,totalassets,Total Assets,=,debit,usd,262677000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,,2019-03-31,2019-05-09 16:03:06+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,,2019-03-31,2019-05-09 16:03:06+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2015000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,,2019-03-31,2019-05-09 16:03:06+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,10091000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,,2019-03-31,2019-05-09 16:03:06+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,1073000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,,2019-03-31,2019-05-09 16:03:06+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,13179000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,,2019-03-31,2019-05-09 16:03:06+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,,2019-03-31,2019-05-09 16:03:06+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,559000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,,2019-03-31,2019-05-09 16:03:06+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,559000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,,2019-03-31,2019-05-09 16:03:06+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,13738000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,,2019-03-31,2019-05-09 16:03:06+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,,2019-03-31,2019-05-09 16:03:06+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,940703000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,,2019-03-31,2019-05-09 16:03:06+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-691885000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,,2019-03-31,2019-05-09 16:03:06+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,121000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,,2019-03-31,2019-05-09 16:03:06+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,248939000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,,2019-03-31,2019-05-09 16:03:06+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,248939000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,,2019-03-31,2019-05-09 16:03:06+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,248939000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,,2019-03-31,2019-05-09 16:03:06+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,262677000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,,2019-06-30,2019-08-08 16:01:56+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,34876000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,,2019-06-30,2019-08-08 16:01:56+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,198498000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,,2019-06-30,2019-08-08 16:01:56+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,415000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,,2019-06-30,2019-08-08 16:01:56+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3719000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,,2019-06-30,2019-08-08 16:01:56+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,237508000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,,2019-06-30,2019-08-08 16:01:56+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1458000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,,2019-06-30,2019-08-08 16:01:56+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,7931000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,,2019-06-30,2019-08-08 16:01:56+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1326000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,,2019-06-30,2019-08-08 16:01:56+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,152000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,,2019-06-30,2019-08-08 16:01:56+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,9409000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,,2019-06-30,2019-08-08 16:01:56+00:00,,totalassets,Total Assets,=,debit,usd,248375000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,,2019-06-30,2019-08-08 16:01:56+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,,2019-06-30,2019-08-08 16:01:56+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4590000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,,2019-06-30,2019-08-08 16:01:56+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,10771000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,,2019-06-30,2019-08-08 16:01:56+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,861000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,,2019-06-30,2019-08-08 16:01:56+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,16222000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,,2019-06-30,2019-08-08 16:01:56+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,,2019-06-30,2019-08-08 16:01:56+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,510000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,,2019-06-30,2019-08-08 16:01:56+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,510000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,,2019-06-30,2019-08-08 16:01:56+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,16732000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,,2019-06-30,2019-08-08 16:01:56+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,,2019-06-30,2019-08-08 16:01:56+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,942661000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,,2019-06-30,2019-08-08 16:01:56+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-711311000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,,2019-06-30,2019-08-08 16:01:56+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,293000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,,2019-06-30,2019-08-08 16:01:56+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,231643000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,,2019-06-30,2019-08-08 16:01:56+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,231643000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,,2019-06-30,2019-08-08 16:01:56+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,231643000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,,2019-06-30,2019-08-08 16:01:56+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,248375000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,,2019-09-30,2019-11-07 16:06:26+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,43567000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,,2019-09-30,2019-11-07 16:06:26+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,152000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,,2019-09-30,2019-11-07 16:06:26+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,110121000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,,2019-09-30,2019-11-07 16:06:26+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,236000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,,2019-09-30,2019-11-07 16:06:26+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3764000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,,2019-09-30,2019-11-07 16:06:26+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,157840000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,,2019-09-30,2019-11-07 16:06:26+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,949000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,,2019-09-30,2019-11-07 16:06:26+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,75274000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,,2019-09-30,2019-11-07 16:06:26+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2279000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,,2019-09-30,2019-11-07 16:06:26+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,,2019-09-30,2019-11-07 16:06:26+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,77553000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,,2019-09-30,2019-11-07 16:06:26+00:00,,totalassets,Total Assets,=,debit,usd,236342000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,,2019-09-30,2019-11-07 16:06:26+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,,2019-09-30,2019-11-07 16:06:26+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3144000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,,2019-09-30,2019-11-07 16:06:26+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,13710000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,,2019-09-30,2019-11-07 16:06:26+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,754000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,,2019-09-30,2019-11-07 16:06:26+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,17608000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,,2019-09-30,2019-11-07 16:06:26+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,,2019-09-30,2019-11-07 16:06:26+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1518000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,,2019-09-30,2019-11-07 16:06:26+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1518000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,,2019-09-30,2019-11-07 16:06:26+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,19126000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,,2019-09-30,2019-11-07 16:06:26+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,,2019-09-30,2019-11-07 16:06:26+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,947887000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,,2019-09-30,2019-11-07 16:06:26+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-730894000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,,2019-09-30,2019-11-07 16:06:26+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,223000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,,2019-09-30,2019-11-07 16:06:26+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,217216000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,,2019-09-30,2019-11-07 16:06:26+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,217216000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,,2019-09-30,2019-11-07 16:06:26+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,217216000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,,2019-09-30,2019-11-07 16:06:26+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,236342000.0
